Active ingredient
Teriparatide
13 finished FDA listings contain Teriparatide as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- PALOPEGTERIPARATIDE, TERIPARATIDE, TERIPARATIDE ACETATE
- Dosage forms
- Injection, Injection, Solution
- Routes
- Subcutaneous
- Manufacturers / labelers
- 9
- Strengths listed
- 168 ug/.56ml · 250 ug/ml · 294 ug/.98ml · 420 ug/1.4ml
- Brand names in FDA listings
- Bonsity, Forteo, Yorvipath
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 32915
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 021318 | LILLY | 2002-11-26 | 4 |
| NDA 211939 | ALVOGEN | 2019-10-04 | 2 |
| ANDA 208569 | TEVA PHARMS USA | 2023-11-16 | 1 |
| ANDA 211097 | APOTEX | 2023-11-16 | 1 |
| NDA 216490 | ASCENDIS PHARMA BONE | 2024-08-09 | 3 |
| ANDA 213641 | AMPHASTAR PHARMS INC | 2025-12-12 | 2 |
Official labeling on DailyMed
- FORTEO (TERIPARATIDE) INJECTION, SOLUTION [ELI LILLY AND COMPANY] · version 44 · 2026-08-19
- YORVIPATH (PALOPEGTERIPARATIDE) INJECTION, SOLUTION [ASCENDIS PHARMA, ENDOCRINOLOGY, INC.] · version 8 · 2026-08-17
- TERIPARATIDE INJECTION [BLUEPOINT LABORATORIES] · version 1 · 2026-03-20
- TERIPARATIDE INJECTION [AMPHASTAR PHARMACEUTICALS, INC.] · version 2 · 2025-12-24
- TERIPARATIDE INJECTION, SOLUTION [PRASCO LABORATORIES] · version 8 · 2025-08-01
- BONSITY (TERIPARATIDE) INJECTION, SOLUTION [ALVOGEN INC.] · version 1 · 2025-06-09
- TERIPARATIDE INJECTION, SOLUTION [ALVOGEN, INC.] · version 8 · 2025-06-02
- TERIPARATIDE INJECTION, SOLUTION [TEVA PHARMACEUTICALS USA, INC.] · version 3 · 2025-03-13
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.